GONADORELIN 10 MG

Gonadorelin 10 mg – Peptide Hubs

Gonadorelin is a synthetic analog of natural gonadotropin-releasing hormone (GnRH), used in research to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary. The 10 mg lyophilized format by Peptide Hubs is designed for precise hormonal research involving fertility, testosterone regulation, and hypothalamic-pituitary-gonadal (HPG) axis function.

Mechanism of Action

Gonadorelin binds to GnRH receptors in the pituitary gland, leading to an acute surge in LH and FSH. This in turn stimulates the gonads to produce testosterone or estrogen depending on the sex of the model organism. It is often used to evaluate fertility function, testicular recovery, and feedback mechanisms. Gonadorelin is also explored in studies related to hypogonadism and HCG/LH synergy. See this NCBI resource on Gonadorelin pharmacology.

Primary Research Applications

• Stimulation of LH and FSH release in HPG axis models
• Investigation of fertility and testosterone recovery
• Evaluation of hypothalamic or pituitary function
• Comparative studies with HCG or Clomiphene Citrate

Gonadorelin may be stacked with HCG 2500 IU or Clomiphene Citrate for post-cycle therapy (PCT) studies or testosterone reactivation protocols. It can also be used in cycles evaluating the impact of androgens on fertility markers when used alongside compounds like GHRP-6 or DSIP.

Suggested Experimental Use

• Dosage: 100–500 mcg per dose in single or pulsatile protocols
• Administration: Subcutaneous or intravenous injection
• Cycle Duration: Short-term stimulation (1–14 days typical in models)

Stacking Options

• GHRP-2 – for synergy in GH + LH/FSH pulse studies
• Chonluten – to study hormone–immune axis balance
• AOD 9604 – to explore gonadal recovery and fat regulation
• GHK Basic – for testicular support and recovery analysis

Safety & Legal Status

Gonadorelin 10 mg is intended strictly for **research purposes only**. It is not approved for medical use and must not be used in humans outside controlled lab environments. No aromatization, liver toxicity, or androgenic activity is reported. Short half-life may require frequent dosing in research protocols. For ongoing studies, visit ClinicalTrials.gov.

Frequently Asked Questions